Analystreport

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) was downgraded by analysts at Roth Capital from a "strong-buy" rating to a "hold" rating.

Cyclacel Pharmaceuticals, Inc.  (CYCC) 
Last cyclacel pharmaceuticals, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.cyclacel.com/investor-relations